Strides Pharma Science informs about press release

18 Dec 2020 Evaluate
Strides Pharma Science has informed that it has enclosed press release titled, ‘Strides receives USFDA approval for Oxybutynin Chloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

871.55 -1.60 (-0.18%)
17-Dec-2025 11:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.00
Dr. Reddys Lab 1276.70
Cipla 1494.10
Zydus Lifesciences 917.20
Lupin 2114.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×